-Data management company Crate.io receives industry recognition SAN FRANCISCO–(BUSINESS WIRE)–Crate.io, the data management company, today…
Distinction Showcases Outstanding Channel Leadership and Commitment to Innovative Partner Program AUSTIN, Texas–(BUSINESS WIRE)–M-Files Corporation,…
Online commerce powerhouses innovate, iterate and turn disruption into opportunities as retail continues its rapid…
Merger includes C$20 million investment to accelerate access to genomics-based testing for cancer treatment by…
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
The latest release of Ballerina open-source language extends unique ability to simultaneously code using text…
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15,…
BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
• FDA Agreed to PolyPid Request for the Addition of an Unblinded Interim Analysis in…
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
– In vitro studies indicate IGM-6268 exhibits potent neutralization activity against the Omicron variant and all other…
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited…
11th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country’s Largest Beer…
NEW YORK and VIENNA, Austria, Feb. 09, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
— Phase 1/2 ABILITY study of MDNA11 on track with first set of efficacy results…
–FC2 Prescription Business Entering 6th Year of Growth — –FDA Approves Company’s ENTADFI™, New Treatment…